Grace Jablonski, APRN
Family · Providence, RINPI 1467201350
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 102 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 18 manufacturers, the largest accounting for just 22.1% — the pattern of someone who eats at a lot of different presentations.
Across 102 payments — averaging $21.60 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$487
- Takeda Pharmaceuticals U.S.A., Inc.$308
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$290
- Ardelyx, Inc.$274
- Gilead$160
- Braintree Laboratories, Inc.$138
- plus $547 from 12 others
What the payments were for
- Food & beverage$2,203100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 28 | $487 |
| Takeda Pharmaceuticals U.S.A., Inc. | 13 | $308 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 12 | $290 |
| Ardelyx, Inc. | 12 | $274 |
| Gilead | 7 | $160 |
| Braintree Laboratories, Inc. | 6 | $138 |
| Madrigal Pharmaceuticals | 3 | $86 |
| Ironwood Pharmaceuticals, Inc | 4 | $76 |
| Johnson & Johnson | 3 | $64 |
| Intercept Pharmaceuticals, Inc. | 3 | $63 |
| Aimmune Therapeutics, Inc. | 2 | $49 |
| Lilly USA, LLC | 2 | $48 |
| QOL Medical, LLC | 1 | $39 |
| Phathom Pharmaceuticals, Inc. | 1 | $35 |
| Daiichi Sankyo Inc. | 2 | $34 |
| Novo Nordisk | 1 | $23 |
| Orphalan Inc | 1 | $17 |
| Ferring Pharmaceuticals Inc. | 1 | $13 |
How this compares
$2,203 in reported general payments places this provider in the 85th percentile of 457 family providers in Rhode Island.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Famotidine | 15 | $542 |
| Omeprazole | 25 | $441 |
Paid to pharmacies, not to this prescriber.
Other family in Providence
- Jeannie-Mae DurfeeProvidence$8K
- Shandrea RodriguezProvidence$8K
- Colleen FullertonProvidence$8K
- Abbey Barkley DavisProvidence$7K
- Inna YakirevichProvidence$7K
- Dennis RotondiProvidence$5K
- Michael MoylanProvidence$5K
- Breanne St MartinProvidence$4K
- Caroline KinneyProvidence$4K
- Vanessa LopezProvidence$4K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.